New benzothiazinone derivatives and their use as antibacterial agents

Details for Australian Patent Application No. 2006343832 (hide)

Owner LEIBNIZ INSTITUTE FOR NATURAL PRODUCT RESEARCH AND INFECTION BIOLOGY E.V. HANSKNOLL-INSTITUT (HKI)

Inventors Mollmann, Ute; Makarov, Vadim A.; Cole, Stewart T.

Agent Houlihan2

Pub. Number AU-B-2006343832

PCT Pub. Number WO2007/134625

Filing date 24 May 2006

Wipo publication date 29 November 2007

Acceptance publication date 21 July 2011

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

22 January 2009 PCT application entered the National Phase

  PCT publication WO2007/134625 Priority application(s): WO2007/134625

21 July 2011 Application Accepted

  Published as AU-B-2006343832

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006343839-Closure device for closing a container, and method of producing such a closure device

2006343808-Inhibitor of VEGF receptor and HGF receptor signaling